Company intelligence / Profile preview

Harley Street

London, United Kingdomtheharleystreet.com ↗

Ownership: Private
Development stage: Other

Overview

The group is focused on delivering personalized preventative care and regenerative therapies globally through partnerships such as with Orgenesis. They aim to launch wellness products including immune cell banking and stem cell-based therapies by end of 2024. No specific clinical trial results disclosed yet.

Therapeutic areas: OtherImmunology
Modalities: Cell therapyStem cell therapy
Industry: Biotech

Partnerships

Orgenesis – strategic partnership to launch global longevity/wellness initiative leveraging both companies' expertise in biotech innovation and healthcare delivery networks

Beyond the preview

Go deeper on Harley Street.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Harley Street.

Explore the full profile